915
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Ethanol extract of Butea monosperma bark modulates dyslipidemia in streptozotocin-induced diabetic rats

&
Pages 1021-1027 | Received 10 Oct 2013, Accepted 12 Dec 2013, Published online: 12 Mar 2014

References

  • Amos AF, McCarty DJ, Zimmet P. (1997). The rising global burden of diabetes and its complications: Estimates and projections to the year 2010. Diabet Med 14:S1–85
  • Babu PS, Srivivasan K. (1997). Hypolipidemic action of curcumin, the active principle of turmeric in streptozotocin induced diabetic rats. Mol Cell Biochem 166:169–75
  • Barneo L, Esteban MM, Garcia Pravia C, et al. (1990). Normalization of altered liver function tests after islet transplantation in diabetic rats. Diabet Metab 16:284–9
  • Betteridge J. (1997). Lipid disorders in diabetes mellitus. In: Pickup JC, Williams G, eds. Textbook of Diabetes. London: Blackwell Science, 1–35
  • Bhandari U, Kanojia R, Pillai KK. (2005). Effect of ethanolic extract of Zingiber officinale on dyslipidaemia in diabetic rats. J Ethnopharmacol 97:227–30
  • Chattopadhyaya R, Pathak D, Jindal DP. (1996). Antihyperlipidemic agents. A review. Indian Drugs 33:85–97
  • Dirican M, Serdar Z, Sarandol E, Gur ES. (2003). Lecithin: Cholesterol acyltransferase activity and cholesteryl ester transfer rate in patients with diabetes mellitus. Turk J Med Sci 33:95–101
  • Divya BT, Mini S. (2011). In vitro radical scavenging activity of different extracts of Butea monosperma bark. Int J Curr Pharm Res 3:114–16
  • Ercyias F, Taneli F, Arslan B, Uslu Y. (2004). Glycemic control, oxidative stress and lipid profile in children with type 1 diabetes mellitus. Arch Med Res 35:134–40
  • Farmer JA. (1998). Aggressive lipid therapy in the statin era. Prog Cardiovasc Dis 41:71–94
  • Ferner RE, Neil HAW. (1988). Sulphonylureas and hypoglycemia. Br Med J 296:949–50
  • Franceschini G, Maderna P, Sirtori CR. (1991). Reverse cholesterol transport: Physiology and pharmacology. Atherosclerosis 88:99–107
  • George F, Zohar K, Harinder PS, Makkar Klaus B. (2002). The biological action of saponins in animal systems: A review. Br J Nutr 88:587–605
  • Gomes A, Vedasiromoni JR, Das M, et al. (2001). Antihyperglycemic effect of black tea (Camellia sinensis) in rat. J Ethnopharmacol 27:243–75
  • Haffner SM, Lehtos S, Ronnemaa T, et al. (1998). Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229–34
  • Kannel WB, McGee DL. (1979). Diabetes and cardiovascular disease. The Framingham study. JAMA 241:2035–8
  • Kim SH, Hyun SH, Choung SY. (2006). Anti-diabetic effect of cinnamon extract on blood glucose in db/db mice. J Ethnopharmacol 104:119–23
  • Koh HJ, Lee SM, Son BG, et al. (2004). Cytosolic NAD+ dependent isocitrate dehydrogenase plays a role in lipid metabolism. Biol Chem 279:19968–74
  • Kornberg A, Horecker CB. (1955). Glucose-6-phosphate dehydrogenase. In: Colowick SP, Kaplan NO, eds. Methods in Enzymology. New York: Academic Press, 323–7
  • Lowry OH, Roesborough MJ, Farr AL, Randall RJ. (1951). Protein measurement with Folin’s phenol reagent. J Biol Chem 193:265–75
  • Mengi SA, Deshpande SG. (1999). Anti-inflammatory activity of Butea frondosa leaves. Fitoterapia 70:521–2
  • Mooradian AD, Wong NCW, Shah GN. (1997). Apolipoprotein A1 expression in young and aged rats is modulated by dietary carbohydrates. Metabolism 46:1132–6
  • Ochoa S. (1955a). Malic enzyme. In: Colowick SP, Kaplan NO, eds. Methods in Enzymology. New York: Academic Press, 739–53
  • Ochoa S. (1955b). Isocitric dehydrogenase system (TPN) from pig heart. In: Colowick SP, Kaplan NO, eds. Methods in Enzymology. New York: Academic Press, 699–700
  • Patil MV, Pawar S, Patil DA. (2006). Ethnobotany of Butea monosperma (Lam.) Kuntze in North Maharashtra, India. Nat Prod Rad 5:323–5
  • Pupim LB, Heimburger Q, Qureshi AR, et al. (2005). Accelerated lean body mass loss in incident chronic dialysis patients with diabetic mellitus. Kidney Int 68:2368–74
  • Rao AV, Ramakrishnan S. (1975). Indirect assessment of hydroxymethylglutaryl-CoA reductase (NADPH) activity in liver tissue. Clin Chem 21:1523–5
  • Salimuddin, Upadhyaya KC, Baquer NZ. (1999). Effects of vanadate on expression of liver arginase in experimental diabetic rats. IUBMB 48:237–40
  • Sambaiah K, Satyanarayana MN. (1982). Influence of red pepper and capsaicin on body composition and lipogenesis in rats. J Biosci 4:425–30
  • Saravanan R, Rajendra Prasad N, Pugalandi KV. (2003). Effect of Piper beetle leaf extract on alcoholic toxicity in the rat brain. J Med Food 6:261–5
  • Scalbert A, Johnson IT, Saltmarsh M. (2005). Polyphenols: Antioxidants and beyond. Am J Clin Nutr 81:S215–17
  • Sharma AK, Deshwal N. (2011). An overview: On phytochemical and pharmacological studies of Butea monosperma. Int J Pharm Tech Res 3:864–71
  • Shirwaikar A, Rajendra K, Kumar CD, Bodla R. (2004). Antidiabetic activity of aqueous leaf extracts of Annona squamosa in streptozotocin–nicotinamide type 2 diabetic rats. J Ethnopharmacol 91:171–5
  • Sofowora H. (1993). Screening plants for bioactive agents. In: Medicinal Plants and Traditional Medicine in Africa. Ibadan, Nigeria: Spectrum Books Ltd, Sunshine House, 134–56
  • Solymoss BC, Marcil M, Chasur M, et al. (1995). Fasting hyperinsulinism, insulin resistance syndrome, and coronary heart disease in men and women. Am J Cardiol 76:1152–6
  • Somani R, Kasture S, Singhai AK. (2006). Antidiabetic potential of Butea monosperma in rats. Fitoterapia 77:86–90
  • Suba V, Murugesan T, Rao RB, et al. (2004). Antidiabetic potential of Barleria lupulina extract in rats. Fitoterapia 75:1–4
  • Tan BK, Tan CH, Pushparaj PN. (2005). Anti-diabetic activity of the semi-purified fractions of Averrhoa bilimbi in high fat diet fed streptozotocin-induced diabetic rats. Life Sci 76:2827–39
  • Thompson Coon JS, Ernst E. (2003). Herbs for serum cholesterol reduction: A systematic view. J Fam Pract 52:468–78
  • Trease GE, Evans WC. (2002). Pharmacology. London: Saunders Publishers, 42–4, 221–9, 246–9, 303–6, 331–2, 391–3
  • Wagman AS, Nuss JM. (2001). Current therapies and emerging targets for the treatment of diabetes. Curr Pharm Des 7:417–50

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.